Literature DB >> 9667684

Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?

O Kiekegaard1, O Mogensen, B Mogensen, S Ahrons.   

Abstract

Cancer antigen 125 (CA 125) and cancer-associated serum antigen (CASA) were measured in 24 women with pelvic masses before and after a gynaecological examination and ultrasonography. CA 125 decreased median 16% after manipulation (P < 0.0001) and CASA decreased median 8% (P = 0.0077). The decline was found in patients with benign tumours as well as in patients with malignant tumours.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9667684      PMCID： PMC2150372          DOI： 10.1038/bjc.1998.334

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  6 in total

1.  Serum CA 125 levels during the menstrual cycle.

Authors:  P Lehtovirta; D Apter; U H Stenman
Journal:  Br J Obstet Gynaecol       Date:  1990-10

2.  Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women.

Authors:  F Kobayashi; N Sagawa; K Nakamura; M Nonogaki; C Ban; S Fujii; T Mori
Journal:  Am J Obstet Gynecol       Date:  1989-03       Impact factor: 8.661

3.  The effect of abdominal surgery on the serum concentration of the tumour-associated antigen CA 125.

Authors:  A G van der Zee; J M Duk; J G Aalders; A H Boontje; K A ten Hoor; H W de Bruijn
Journal:  Br J Obstet Gynaecol       Date:  1990-10

4.  IMx CA 125, an automated microparticle enzyme immunoassay: technical characteristics and clinical usefulness after recalibration.

Authors:  O Mogensen; B Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1995-07       Impact factor: 1.713

5.  CA 125 measurements in ovarian cancer patients during their first postoperative week.

Authors:  O. Mogensen; A. Brock; M. Holm Nyland
Journal:  Int J Gynecol Cancer       Date:  1993-01       Impact factor: 3.437

6.  Predictive and prognostic values of cancer-associated serum antigen (CASA) and cancer antigen 125 (CA 125) levels prior to second-look laparotomy for ovarian cancer.

Authors:  O Kierkegaard; O Mogensen; B Mogensen; A Jakobsen
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.